Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel

Sumbul A. T., Sezer A., Abali H., Kose F., Gultepe I., Mertsoylu H., ...More

INTERNATIONAL UROLOGY AND NEPHROLOGY, vol.46, no.8, pp.1531-1535, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 46 Issue: 8
  • Publication Date: 2014
  • Doi Number: 10.1007/s11255-014-0664-7
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1531-1535
  • Bezmialem Vakıf University Affiliated: Yes


The neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammatory response and evidences for the relationship between NLR and the response to treatment gradually increases in cancer patients. In this study, we aimed to investigate the effect of the pretreatment NLR and other factors related to the patient on predicting the outcome of docetaxel + prednisone chemotherapy in prostate cancer patients who become castration resistant.